Browse by Phase
Phase 3 Clinical Trials
Phase 3 trials compare a new drug or treatment against the current standard of care in a large population (300–3,000+ participants). Successful Phase 3 results are the basis for regulatory approval.
Total Trials
514
Recruiting Now
514
Top Conditions in Phase 3
NCT05877014 Phase 3
Recruiting
Unipolar Versus Bipolar Interlocking in Humeral Shaft Fractures in Adults
Condition
Humeral Shaft Fracture
Enrollment
390 pts
Location
France
Sponsor
Centre Hospitalier Universitai
NCT07003984 Phase 3
Recruiting
A Safety and Immunogenicity Study of CHIKV VLP Vaccine in Children.
Condition
Chikungunya Virus
Enrollment
720 pts
Location
United States, Philippines, Puerto Rico
Sponsor
Bavarian Nordic
NCT06893016 Phase 3
Recruiting
Evaluation of RAY1225 in Adult Participants Who Have Obesity or Are Overweight
Condition
Obesity
Enrollment
640 pts
Location
China
Sponsor
Guangdong Raynovent Biotech Co
NCT04376034 Phase 3
Recruiting
Convalescent Plasma Collection and Treatment in Pediatrics and Adults
Condition
COVID19
Enrollment
240 pts
Location
United States
Sponsor
West Virginia University
NCT05824871 Phase 3
Recruiting
A Phase III Study of Oral Sudapyridine (WX-081) Tablets in Rifampicin-Resistant ...
Condition
Rifampin-Resistant Pulmonary Tuberculosis
Enrollment
450 pts
Location
China
Sponsor
Shanghai Jiatan Pharmatech Co.
NCT06544499 Phase 3
Recruiting
A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participan...
Condition
Primary Immune Thrombocytopenia (ITP)
Enrollment
69 pts
Location
United States, Austria, Bulgaria
Sponsor
argenx
NCT05939414 Phase 3
Recruiting
An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Obse...
Condition
Oligometastatic Prostate Cancer (OMPC)
Enrollment
450 pts
Location
United States, Argentina, Australia
Sponsor
Novartis Pharmaceuticals
NCT02535221 Phase 3
Recruiting
Neoadjuvant Endocrine Therapy Versus Chemotherapy in Premenopausal Patients With...
Condition
Breast Cancer
Enrollment
234 pts
Location
China
Sponsor
Peking University
NCT05943821 Phase 3
Recruiting
The Effect of Allopurinol on the Risk of Cardiovascular Events in Patients with ...
Condition
Cardiovascular Diseases
Enrollment
1,116 pts
Location
Poland
Sponsor
Poznan University of Medical S
NCT06459687 Phase 3
Recruiting
Phase III Study of Socazolimab as First-Line Treatment in Persistent, Recurrent,...
Condition
Cervical Cancer
Enrollment
440 pts
Location
China
Sponsor
Lee's Pharmaceutical Limited
NCT04204252 Phase 3
Recruiting
Phase III, Efficacy and Safety of "Kamada-AAT for Inhalation"
Condition
Alpha 1-Antitrypsin Deficiency
Enrollment
220 pts
Location
Belgium, Finland, Ireland
Sponsor
Kamada, Ltd.
NCT06575192 Phase 3
Recruiting
Evaluation of the Safety and Effectiveness of ARTIA Reconstructive Tissue Matrix...
Condition
Breast Reconstruction
Enrollment
783 pts
Location
United States
Sponsor
AbbVie
NCT06079671 Phase 3
Recruiting
Study of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (e...
Condition
Locally Advanced Cervical Cancer
Enrollment
800 pts
Location
United States, Brazil, Canada
Sponsor
AstraZeneca
NCT06806592 Phase 3
Recruiting
A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to ...
Condition
Interstitial Lung Diseases
Enrollment
400 pts
Location
United States, Australia, Austria
Sponsor
Boehringer Ingelheim
NCT06032559 Phase 3
Recruiting
Implementation and Effectiveness of Mindfulness Oriented Recovery Enhancement as...
Condition
Opioid Use
Enrollment
450 pts
Location
United States
Sponsor
Rutgers, The State University
NCT04216186 Phase 3
Recruiting
Role of Coenzyme Q in ADHD in Children
Condition
ADHD
Enrollment
40 pts
Location
Egypt
Sponsor
Sherief Abd-Elsalam
NCT06313086 Phase 3
Recruiting
DP303c Versus Trastuzumab Emtansine in in Patients With HER2-positive Advanced B...
Condition
HER2-positive Breast Cancer
Enrollment
442 pts
Location
China
Sponsor
CSPC ZhongQi Pharmaceutical Te
NCT04280822 Phase 3
Recruiting
Neo-adjuvant Immunochemotheray Versus Neo-adjuvant Chemotherapy for Resectable E...
Condition
Esophageal Cancer
Enrollment
400 pts
Location
China
Sponsor
Henan Cancer Hospital
NCT04168502 Phase 3
Recruiting
Gemtuzumab Chemotherapy MRD Levels; Adult Untreated, de Novo, Fav Interm Risk AM...
Condition
Acute Myeloid Leukemia
Enrollment
414 pts
Location
Italy
Sponsor
Gruppo Italiano Malattie EMato
NCT05922345 Phase 3
Recruiting
Evaluation of the Efficacy and Safety of AL2846 Capsule Combined With TQB2450 In...
Condition
Non-small Cell Lung Cancer
Enrollment
518 pts
Location
China
Sponsor
Chia Tai Tianqing Pharmaceutic
NCT06496581 Phase 3
Recruiting
Standard of Care +/- 177Lu-PSMA-617 In de Novo mHSPC Patients With Poor PSA Resp...
Condition
Prostate Cancer Metastatic
Enrollment
500 pts
Location
France
Sponsor
UNICANCER
NCT05918094 Phase 3
Recruiting
Comparing Modified XELOX Plus Sintilimab With Standard XELOX Plus Sintilimab in ...
Condition
Gastric Cancer
Enrollment
540 pts
Location
China
Sponsor
Sun Yat-sen University
NCT05339139 Phase 3
Recruiting
SAfety of Regional Citrate Anticoagulation (SARCA Study)
Condition
Acute Kidney Injury
Enrollment
50 pts
Location
United States
Sponsor
Fresenius Medical Care North A
NCT04184505 Phase 3
Recruiting
Feasibility of Allogeneic Stem Cell Transplantation in Higher-risk-MDS (ACROBAT)
Condition
High-risk MDS
Enrollment
274 pts
Location
Italy
Sponsor
Gruppo Italiano Malattie EMato
NCT07025629 Phase 3
Recruiting
Dapagliflozin for Cardio-renal Protection After ICU Discharge
Condition
Heart Failure and Chronic Kidney Disease Post-ICU
Enrollment
600 pts
Location
France
Sponsor
Assistance Publique - Hôpitaux
Page 1 of 21 — 514 trials total